Vaxigrip Tetra
Details for Vaxigrip Tetra vaccine and its components.
Sponsor:
Sanofi-Aventis Australia
Administration route:
Intramuscular injection, Subcutaneous injection
Vaccine group:
All people aged ≥6 months
Registered for use in people aged ≥6 months.
Quadrivalent inactivated influenza vaccine
Each 0.5 mL monodose pre-filled syringe contains:
- 15 µg haemagglutinin of each of the 4 recommended influenza virus strains
Also contains traces of:
- ovalbumin (≤ 0.05 µg)
- neomycin (≤ 10.1 pg)
- formaldehyde (≤ 30 µg)
- octoxinol-9 (≤ 222.5 µg)
Page history
Last updated:
9 April 2020
Last reviewed:
9 April 2020
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/vaxigrip-tetra.